TumCD Cancer Research Results
TumCD, Tumor Cell Death: Click to Expand ⟱
| Source: |
| Type: |
Tumor Cell Death
|
CRC, Colorectal Cancer: Click to Expand ⟱
Colorectal cancer is a broader term that encompasses both colon and rectal cancer.
|
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
CRC, |
Caco-2 |
|
|
|
- |
in-vitro, |
CRC, |
SW48 |
|
|
|
ATP↓, TumCD↑, selectivity↑, toxicity↓, OS↑, HK2?, Cyt‑c↑, eff↑, p‑Akt↑,
eff↑, TumCD↑, ROS↑, Bacteria↓,
TumCD↑,
| - |
in-vitro, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
Hepat, |
HepG2 |
|
|
|
- |
in-vitro, |
CRC, |
SW-620 |
|
|
|
TumCD↑,
| - |
in-vitro, |
CRC, |
T24/HTB-9 |
|
|
|
- |
in-vitro, |
Bladder, |
UMUC3 |
|
|
|
- |
in-vitro, |
Bladder, |
5637 |
|
|
|
TumCD↑, Apoptosis↑, TumCCA↑, CycB/CCNB1↓, cycA1/CCNA1↓, CDK2↓, CDC25↓, mtDam↑, BAX↑, cl‑PARP↑, Casp3↑, Casp8↑, Casp9↑, Snail↓, Slug↓, MMP9↓, selectivity↑, MMP↓, ROS∅, TumCMig↓, TumCI↓,
TumCD↑, TumCMig↓, Ca+2↑,
| - |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vitro, |
CRC, |
HCT116 |
|
|
|
AntiCan↑, chemoPv↑, Apoptosis↑, TumCI↓, Casp↑, p16↑, P21↑, TumCCA↑, ROS↓, eff↓, TumCD↑, TumCG↓, cellSen↑, *ROS↓,
| - |
vitro+vivo, |
CRC, |
COLO205 |
|
|
|
- |
in-vitro, |
CRC, |
HCT116 |
|
|
|
Akt↑, AntiTum↑, IL8↓, p‑IKKα↓, NF-kB↓, TumCD↑, Apoptosis↑, cFLIP↓, Bcl-2↓, Bcl-xL↓, TumVol↓,
| - |
vitro+vivo, |
CRC, |
HCT116 |
|
|
|
- |
NA, |
Nor, |
NCM460 |
|
|
|
TumCD↑, Apoptosis↑, Casp8↑, selectivity↑, TumCMig↓, selectivity↑, Dose↝, toxicity↓, TumCG↓, MMP↓, mt-ROS↑, *ROS↓, BID↑, Bcl-2↓, PARP↓, NF-kB↑, *NF-kB↓, Casp1↑, *Casp1↓, COX2↑, OXPHOS↓, ETC↓,
| - |
in-vitro, |
CRC, |
DLD1 |
|
|
|
- |
in-vitro, |
Nor, |
CCD841 |
|
|
|
tumCV↓, Apoptosis↑, selectivity↑, Casp↑, Bcl-2↓, MMP↓, TumCD↑, MAPK↓, JNK↓, PI3K↓, Akt↓, NF-kB↓, STAT↓, Diff↓, P53↑, PARP↓,
| - |
vitro+vivo, |
CRC, |
HT29 |
|
|
|
- |
in-vitro, |
CRC, |
COLO205 |
|
|
|
TumCD↑, Casp3↑, Casp6↑, Casp8↑, Casp9↑, cl‑PARP↑, Bcl-xL↓, ROS↑, i-H2O2↑, eff↓, mtDam↑, MMP↓, Cyt‑c↑, AIF↑, TumCG↓,
| - |
in-vitro, |
PC, |
MIA PaCa-2 |
|
|
|
- |
in-vitro, |
CRC, |
SW-620 |
|
|
|
- |
in-vitro, |
NA, |
HT1080 |
|
|
|
- |
in-vitro, |
Pca, |
PC3 |
|
|
|
- |
in-vitro, |
OS, |
U2OS |
|
|
|
- |
in-vitro, |
BC, |
MCF7 |
|
|
|
- |
in-vitro, |
Nor, |
CCD-18Co |
|
|
|
TumCD↑, eff↑, *TumCG∅,
p38↑, ER Stress↑, Casp3↑, Casp7↑, TumCD↑, Apoptosis↑, TumCP↑, HSP27↓,
| - |
in-vitro, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
BC, |
MCF7 |
|
|
|
TrxR1?, TumCD↑, ROS↑, GSH↓, eff↑,
AntiTum↑, Apoptosis↑, mtDam↑, ROS↑, SOD1↓, ChemoSen↑, CSCs↑, ALDH↓, TumCG↓, TumCP↓, TumCD↑, ATP↓,
| - |
in-vitro, |
GBM, |
U87MG |
|
|
|
- |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
BC, |
MCF7 |
|
|
|
- |
in-vitro, |
Pca, |
PC3 |
|
|
|
- |
in-vitro, |
CRC, |
HT-29 |
|
|
|
- |
in-vitro, |
Nor, |
SVGp12 |
|
|
|
Ferroptosis↑, xCT↓, GSH↓, GPx4↓, Iron↑, lipid-P↑, ROS↑, eff↓, TumCP↓, TumCD↑,
| - |
in-vivo, |
GBM, |
U87MG |
|
|
|
- |
in-vitro, |
CRC, |
HCT116 |
|
|
|
eff↓, TumCD↑, ChemoSen↑, ROS⇅, DNAdam↑, PARP↑, NAD↓, Glycolysis↓, Fenton↑, lipid-P↑, eff↓, H2O2↑, other↝,
Showing Research Papers: 1 to 17 of 17
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 17
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
Fenton↑, 1, Ferroptosis↑, 1, GPx4↓, 1, GSH↓, 2, H2O2↑, 1, i-H2O2↑, 1, Iron↑, 1, lipid-P↑, 2, OXPHOS↓, 1, ROS↓, 1, ROS↑, 5, ROS⇅, 1, ROS∅, 1, mt-ROS↑, 1, SOD1↓, 1, TrxR1?, 1, xCT↓, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
AIF↑, 1, ATP↓, 2, CDC25↓, 1, ETC↓, 1, MMP↓, 4, mtDam↑, 3,
Core Metabolism/Glycolysis(tgid=4) ⓘ
Glycolysis↓, 1, HK2?, 1, NAD↓, 1,
Cell Death(tgid=5) ⓘ
Akt↓, 1, Akt↑, 1, p‑Akt↑, 1, Apoptosis↑, 7, BAX↑, 1, Bcl-2↓, 3, Bcl-xL↓, 2, BID↑, 1, Casp↑, 2, Casp1↑, 1, Casp3↑, 3, Casp6↑, 1, Casp7↑, 1, Casp8↑, 3, Casp9↑, 2, cFLIP↓, 1, Cyt‑c↑, 2, Ferroptosis↑, 1, JNK↓, 1, MAPK↓, 1, p38↑, 1, TumCD↑, 17,
Transcription & Epigenetics(tgid=7) ⓘ
other↝, 1, tumCV↓, 1,
Protein Folding & ER Stress(tgid=8) ⓘ
ER Stress↑, 1, HSP27↓, 1,
DNA Damage & Repair(tgid=10) ⓘ
DNAdam↑, 1, p16↑, 1, P53↑, 1, PARP↓, 2, PARP↑, 1, cl‑PARP↑, 2,
Cell Cycle & Senescence(tgid=11) ⓘ
CDK2↓, 1, cycA1/CCNA1↓, 1, CycB/CCNB1↓, 1, P21↑, 1, TumCCA↑, 2,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
ALDH↓, 1, CSCs↑, 1, Diff↓, 1, PI3K↓, 1, STAT↓, 1, TumCG↓, 4,
Migration(tgid=13) ⓘ
Ca+2↑, 1, MMP9↓, 1, Slug↓, 1, Snail↓, 1, TumCI↓, 2, TumCMig↓, 3, TumCP↓, 2, TumCP↑, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
cellSen↑, 1, COX2↑, 1, p‑IKKα↓, 1, IL8↓, 1, NF-kB↓, 2, NF-kB↑, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
ChemoSen↑, 2, Dose↝, 1, eff↓, 5, eff↑, 4, selectivity↑, 5,
Functional Outcomes(tgid=23) ⓘ
AntiCan↑, 1, AntiTum↑, 2, chemoPv↑, 1, OS↑, 1, toxicity↓, 2, TumVol↓, 1,
Infection & Microbiome(tgid=24) ⓘ
Bacteria↓, 1,
Total Targets: 95
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
ROS↓, 2,
Cell Death(tgid=5) ⓘ
Casp1↓, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
TumCG∅, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
NF-kB↓, 1,
Total Targets: 4
Scientific Paper Hit Count for: TumCD, Tumor Cell Death
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:6 Cells:% prod#:% Target#:619 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page